3.8 Article

Corticosteroid Administration and Impaired Glycemic Control in Mechanically Ventilated COVID-19 Patients

Journal

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/10892532211043313

Keywords

COVID-19; mechanical ventilation; corticosteroids; dexamethasone; hypoglycemia; hyperglycemia; glycemic control

Categories

Funding

  1. National Institutes of Health (NIH) [K23DA040923]
  2. Agency for Healthcare Research and Quality (AHRQ) [R01HS027795]

Ask authors/readers for more resources

The study found an association between corticosteroid administration and higher incidence of both hyperglycemia and hypoglycemia in COVID-19 patients requiring mechanical ventilation.
Objective Recent clinical trials confirmed the corticosteroid dexamethasone as an effective treatment for patients with COVID-19 requiring mechanical ventilation. However, limited attention has been given to potential adverse effects of corticosteroid therapy. The objective of this study was to determine the association between corticosteroid administration and impaired glycemic control among COVID-19 patients requiring mechanical ventilation and/or veno-venous extracorporeal membrane oxygenation. Design Multicenter retrospective cohort study between March 9 and May 17, 2020. The primary outcome was days spent with at least 1 episode of blood glucose either >180 mg/dL or Setting Twelve hospitals in a United States health system. Patients Adults diagnosed with COVID-19 requiring invasive mechanical ventilation and/or veno-venous extracorporeal membrane oxygenation. Interventions None. Measurements and Main Results We included 292 mechanically ventilated patients. We fitted a quantile regression model to assess the association between steroid administration >= 320 mg methylprednisolone (equivalent to 60 mg dexamethasone) and impaired glycemic control. Sixty-six patients (22.6%) died within 28 days of intensive care unit admission. Seventy-one patients (24.3%) received a cumulative dose of least 320 mg methylprednisolone equivalents. After adjustment for gender, history of diabetes mellitus, chronic liver disease, sequential organ failure assessment score on intensive care unit day 1, and length of stay, administration of >= 320 mg methylprednisolone equivalent was associated with 4 additional days spent with glucose either 180 mg/dL (B = 4.00, 95% CI = 2.15-5.85, P < .001). Conclusions In this cohort study of 292 mechanically ventilated COVID-19 patients, we found an association between corticosteroid administration and higher incidence of both hyperglycemia and hypoglycemia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available